NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Nectero Medical

Nectero Medical

Private
Tempe, ArizonaHealthcare & Life Scienceshttps://necterotherapeutics.com/

Last Round

Series D

Apr 11, 2024

Est. Valuation

$170M

Total Funding Raised

$122.5M

Company Overview

Nectero Medical is a biotechnology company that develops innovative endovascular treatments to stabilize and prevent the rupture of mid-sized abdominal aortic aneurysms.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

medical deviceendovascular therapyaneurysm stabilizationabdominal aortic aneurysmAAAendovascular aneurysm repairEVARminimally invasive surgerycatheter-based devicevascular surgeryinterventional radiologymedtechclinical-stage biotechinvestigational device

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nectero Medical Comps

Public and private peers based on sector, stage, and business model.

Nectero Medical comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Nectero Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series DApr 11, 2024
Series CSep 10, 2021
Series BApr 30, 2020

Nectero Medical Investors

Notable investors and investment history

Nectero Medical investors
InvestorRounds
Aphelion CapitalSeries D
Cadence Healthcare VenturesSeries D
Norwest Venture PartnersSeries D
Boston Scientific CorporationSeries D, Series C
Boston Scientific VenturesSeries C, Series D
BioStar CapitalSeries D
Cadence Healthcare VenturesSeries D

Nectero Medical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Nectero Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Nectero Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersTempe, Arizona
Employee Range34
Year Founded2017
Last FundingApr 11, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.